MARKET

RVVTF

RVVTF

Revive Therapeutics Ltd
OTCMQB

Real-time Quotes | Nasdaq Last Sale

0.350
+0.001
+0.32%
Closed 15:59 06/30 EDT
OPEN
0.349
PREV CLOSE
0.349
HIGH
0.353
LOW
0.341
VOLUME
244.65K
TURNOVER
85.14K
52 WEEK HIGH
0.510
52 WEEK LOW
0.120
MARKET CAP
107.95M
P/E (TTM)
-5.8824
1D
5D
1M
3M
1Y
5Y
Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands
Revive Therapeutics Ltd. (OTC: RVVTF) moved closer towards potential endpoint change in their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19.
Benzinga · 1d ago
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.12% at $0.82
Benzinga · 3d ago
Revive Therapeutics says FDA agrees to changes to late-stage study for COVID-19 therapy
The U.S. FDA has agreed to new primary efficacy endpoints for Revive Therapeutics' (OTCQB:RVVTF) for bucillamine for mild-to- moderate COVID-19. The agency has accepted the company's Data Access Plan that
Seekingalpha · 6d ago
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
FDA accepts Company’s Data Access Plan to determine potential new clinical endpoints to support Emergency Use AuthorizationTORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:...
GlobeNewswire · 6d ago
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71
Benzinga · 06/23 22:22
Psychedelic Stock Gainers And Losers From June 22, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50
Benzinga · 06/22 20:34
Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Benzinga · 06/21 21:43
Psychedelic Stock Gainers And Losers From June 14, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44
Benzinga · 06/14 20:34
More
No Data
Learn about the latest financial forecast of RVVTF. Analyze the recent business situations of Revive Therapeutics Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Actual
Estimate
-0.02-0.01-0.01-0.00
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.17%
Pharmaceuticals & Medical Research
-0.21%
Key Executives
Chairman/Chief Executive Officer/Director
Michael Frank
Chief Financial Officer
Carmelo Marrelli
Independent Director
Joshua Herman
Independent Director
William Jackson
Independent Director
Andrew Lindzon
Independent Director
Christian Scovenna
No Data
No Data
About RVVTF
Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Webull offers kinds of Revive Therapeutics Ltd stock information, including OTCMQB:RVVTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVVTF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RVVTF stock methods without spending real money on the virtual paper trading platform.